Royal Marsden Private Care offers CAR-T therapy for multiple myeloma

The Royal Marsden Private Care has become the first provider in the UK to treat multiple myeloma patients with CAR-T cell therapy outside a clinical trial. Ciltacabtagene autoleucel (cilta-cel) is a type of CAR-T cell therapy developed for the treatment of multiple myeloma – an incurable but treatable blood cancer – that does not respond…